Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...
Illumina reported Q3 2024 revenue of $1.08 billion -- in line with analysts' consensus estimate. Non-GAAP EPS was $1.14, exceeding the $0.879 consensus and indicating strong cost control. Despite ...
Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country.
SHANGHAI, March 4 (Reuters) - China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina (ILMN.O), opens new tab ...
China’s Ministry of Commerce said it would ban Illumina, a San Diego company, from importing its gene-mapping products in China. Illumina is the world’s leading producer of gene-sequencing ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth year in a row to the Dow Jones Best-in-Class World Index and the Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results